Utilization of exacerbation-related drugs by COPD patients with Arg16Gly polymorphism of ADRB2 gene

K. Dmytriiev (Vinnitsya, Ukraine), Y. Mostovoy (Vinnitsya, Ukraine), N. Slepchenko (Vinnitsya, Ukraine), Y. Smereka (Vinnitsya, Ukraine), D. Dmytriiev (Vinnitsya, Ukraine), K. Dmytriieva (Vinnitsya, Ukraine)

Source: International Congress 2022 – COPD management: comorbidities, cohorts and real-world studies

Session: COPD management: comorbidities, cohorts and real-world studies
Session type: Thematic Poster
Number: 2112

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Dmytriiev (Vinnitsya, Ukraine), Y. Mostovoy (Vinnitsya, Ukraine), N. Slepchenko (Vinnitsya, Ukraine), Y. Smereka (Vinnitsya, Ukraine), D. Dmytriiev (Vinnitsya, Ukraine), K. Dmytriieva (Vinnitsya, Ukraine). Utilization of exacerbation-related drugs by COPD patients with Arg16Gly polymorphism of ADRB2 gene. 2112

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.